From the perspective of prognostic value, among the six genes used to construct the signature, the protective values of CFHR3 and CD8A have been demonstrated in a variety of tumors, whereas GPX7, FAM83D, EPO, and MSC are involved in tumor progression. The gene discussed is CFHR3; the disease is neoplasm.